Dr. Sarabjit S Chadha is a medical doctor and currently works as deputy regional director, TB and communicable disease, at The International Union against TB and Lung Disease (The Union). He is a leading expert on the disease in the region.
Unless the private health care providers are successfully engaged, it is unlikely that India will achieve the ambitious target of ending TB by 2035. If we don't end the disease in India, we will not end it globally. Sangita Reddy and Sarabjit Chadha analyze how technology-based approaches to supporting TB patients throughout the course of treatment can help.
Incidence of tuberculosis — a disease that affects 9 million people and claims 1.5 million lives each year — will likely flare up in rapidly developing countries because of diabetes, three TB experts from India write in this exclusive commentary.
